203 related articles for article (PubMed ID: 22993231)
1. Intestine-specific expression of Apobec-1 rescues apolipoprotein B RNA editing and alters chylomicron production in Apobec1 -/- mice.
Blanc V; Xie Y; Luo J; Kennedy S; Davidson NO
J Lipid Res; 2012 Dec; 53(12):2643-55. PubMed ID: 22993231
[TBL] [Abstract][Full Text] [Related]
2. Induction of body weight loss through RNAi-knockdown of APOBEC1 gene expression in transgenic rabbits.
Jolivet G; Braud S; DaSilva B; Passet B; Harscoët E; Viglietta C; Gautier T; Lagrost L; Daniel-Carlier N; Houdebine LM; Harosh I
PLoS One; 2014; 9(9):e106655. PubMed ID: 25216115
[TBL] [Abstract][Full Text] [Related]
3. Alternative mRNA splicing and differential promoter utilization determine tissue-specific expression of the apolipoprotein B mRNA-editing protein (Apobec1) gene in mice. Structure and evolution of Apobec1 and related nucleoside/nucleotide deaminases.
Nakamuta M; Oka K; Krushkal J; Kobayashi K; Yamamoto M; Li WH; Chan L
J Biol Chem; 1995 Jun; 270(22):13042-56. PubMed ID: 7768898
[TBL] [Abstract][Full Text] [Related]
4. Superior role of apolipoprotein B48 over apolipoprotein B100 in chylomicron assembly and fat absorption: an investigation of apobec-1 knock-out and wild-type mice.
Kendrick JS; Chan L; Higgins JA
Biochem J; 2001 Jun; 356(Pt 3):821-7. PubMed ID: 11389690
[TBL] [Abstract][Full Text] [Related]
5. APOLIPOPROTEIN B: mRNA editing, lipoprotein assembly, and presecretory degradation.
Davidson NO; Shelness GS
Annu Rev Nutr; 2000; 20():169-93. PubMed ID: 10940331
[TBL] [Abstract][Full Text] [Related]
6. Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1.
Nakamuta M; Chang BH; Zsigmond E; Kobayashi K; Lei H; Ishida BY; Oka K; Li E; Chan L
J Biol Chem; 1996 Oct; 271(42):25981-8. PubMed ID: 8824235
[TBL] [Abstract][Full Text] [Related]
7. Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48.
Hirano K; Young SG; Farese RV; Ng J; Sande E; Warburton C; Powell-Braxton LM; Davidson NO
J Biol Chem; 1996 Apr; 271(17):9887-90. PubMed ID: 8626621
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous expression of apolipoprotein B mRNA editing enzyme and scavenger receptor BI mediated by a therapeutic gene expression system.
Zhong S; Liu C; Haviland D; Doris PA; Teng BB
Atherosclerosis; 2006 Feb; 184(2):264-75. PubMed ID: 15979078
[TBL] [Abstract][Full Text] [Related]
9. Acute modulation of the extent of apoB mRNA editing and the relative rates of syntheses of apoB48 and apoB100 in cultured rat hepatocytes by osmotic and other stress stimuli.
McCahill A; Lankester DJ; Park BS; Price NT; Zammit VA
Mol Cell Biochem; 2000 May; 208(1-2):77-87. PubMed ID: 10939631
[TBL] [Abstract][Full Text] [Related]
10. Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting.
Hersberger M; Patarroyo-White S; Qian X; Arnold KS; Rohrer L; Balestra ME; Innerarity TL
Biochem J; 2003 Jan; 369(Pt 2):255-62. PubMed ID: 12374571
[TBL] [Abstract][Full Text] [Related]
11. Gene transfer of cytidine deaminase apoBEC-1 lowers lipoprotein(a) in transgenic mice and induces apolipoprotein B editing in rabbits.
Hughes SD; Rouy D; Navaratnam N; Scott J; Rubin EM
Hum Gene Ther; 1996 Jan; 7(1):39-49. PubMed ID: 8825867
[TBL] [Abstract][Full Text] [Related]
12. APOBEC1 complementation factor (A1CF) is dispensable for C-to-U RNA editing in vivo.
Snyder EM; McCarty C; Mehalow A; Svenson KL; Murray SA; Korstanje R; Braun RE
RNA; 2017 Apr; 23(4):457-465. PubMed ID: 28069890
[TBL] [Abstract][Full Text] [Related]
13. apoB and apobec1, two genes key to lipid metabolism, are transcriptionally regulated by p53.
Ashur-Fabian O; Har-Zahav A; Shaish A; Wiener Amram H; Margalit O; Weizer-Stern O; Dominissini D; Harats D; Amariglio N; Rechavi G
Cell Cycle; 2010 Sep; 9(18):3761-70. PubMed ID: 20890106
[TBL] [Abstract][Full Text] [Related]
14. Analysis of reptilian APOBEC1 suggests that RNA editing may not be its ancestral function.
Severi F; Chicca A; Conticello SG
Mol Biol Evol; 2011 Mar; 28(3):1125-9. PubMed ID: 21172829
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome-wide sequencing reveals numerous APOBEC1 mRNA-editing targets in transcript 3' UTRs.
Rosenberg BR; Hamilton CE; Mwangi MM; Dewell S; Papavasiliou FN
Nat Struct Mol Biol; 2011 Feb; 18(2):230-6. PubMed ID: 21258325
[TBL] [Abstract][Full Text] [Related]
16. Apobec1 complementation factor (A1CF) and RBM47 interact in tissue-specific regulation of C to U RNA editing in mouse intestine and liver.
Blanc V; Xie Y; Kennedy S; Riordan JD; Rubin DC; Madison BB; Mills JC; Nadeau JH; Davidson NO
RNA; 2019 Jan; 25(1):70-81. PubMed ID: 30309881
[TBL] [Abstract][Full Text] [Related]
17. Complementation of apolipoprotein B mRNA editing by human liver accompanied by secretion of apolipoprotein B48.
Giannoni F; Bonen DK; Funahashi T; Hadjiagapiou C; Burant CF; Davidson NO
J Biol Chem; 1994 Feb; 269(8):5932-6. PubMed ID: 8119937
[TBL] [Abstract][Full Text] [Related]
18. Tissue-specific inhibition of apolipoprotein B mRNA editing in the liver by adenovirus-mediated transfer of a dominant negative mutant APOBEC-1 leads to increased low density lipoprotein in mice.
Oka K; Kobayashi K; Sullivan M; Martinez J; Teng BB; Ishimura-Oka K; Chan L
J Biol Chem; 1997 Jan; 272(3):1456-60. PubMed ID: 8999814
[TBL] [Abstract][Full Text] [Related]
19. Mouse and other rodent models of C to U RNA editing.
Blanc V; Davidson NO
Methods Mol Biol; 2011; 718():121-35. PubMed ID: 21370045
[TBL] [Abstract][Full Text] [Related]
20. Re-editing the paradigm of Cytidine (C) to Uridine (U) RNA editing.
Fossat N; Tam PP
RNA Biol; 2014; 11(10):1233-7. PubMed ID: 25585043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
